Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
SSihuan Pharma Announces Second Anti-Virus Partnership with AMMS | October 17, 2014
MID Labs of California Raises $51 Million from China Investors | October 16, 2014
Sihuan Pharma Buys Rights to Ebola Drug from China's AMMS | October 10, 2014
WuXi PharmaTech Buys XenoBiotic, a US-China CRO | October 1, 2014
Livzon Mabpharm to Develop Epirus Biosimilars in China | September 25, 2014
Blackstone Invests $100 Million In Device Maker Suzhou Xinrong | September 23, 2014
>> See all top stories...
ChinaBio in the News